ClinicalTrials.gg
RecruitingNCT07759115Updated Aug 17, 2026

Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study

An interventional study of Music Training Intervention and Music Listening in Multiple Sclerosis, Pathologic Processes and Demyelinating Autoimmune Diseases, CNS, sponsored by University of Texas at Austin. Recruiting at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-08-17.

Sponsored by University of Texas at Austin · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Aug 2026; still recruiting 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Multiple sclerosis (MS) rates in the U.S. have nearly doubled over the past decade, making it a leading cause of nontraumatic functional impairment in young adults and significantly affecting cognitive function in up to 70% of people with MS. While traditional cognitive rehabilitation methods are limited in sensory engagement, music training offers a multisensory approach that enhances neuroplasticity and improves cognitive functions. This study investigates the feasibility of Music-4-MS, a 12-week music-based eHealth intervention, to support cognitive and emotional health in individuals with MS.

Read the detailed description

Multiple sclerosis (MS) affects more than 2.8 million people worldwide; its prevalence has increased in every region and nearly doubled in the U.S. since 2013. In many countries, MS is the main cause of nontraumatic disability in young adults. The course of MS is unpredictable, and common symptoms in persons with MS include impaired day-to-day activities such as walking, cognitive impairment, vision problems, paresthesia in the extremities, trouble sleeping, and chronic pain. Physical difficulties associated with MS contribute to secondary symptoms of depression, anxiety, and fatigue.

Cognitive impairment affects up to 70% of people with MS, and the incidence of early-onset dementia is 7 times higher than it is in adults without MS. Impairments like slowed processing, poor memory, and learning difficulties impact quality of life, social, and occupational functioning. Working memory deficits are associated with reduced connectivity between brain regions, especially the frontal and parietal lobes, during memory encoding, maintenance, and recall. Cognitive-based rehabilitation, however, can improve memory and learning as well as symptoms of depression and anxiety, which may reinforce cognition. Traditional approaches to cognitive rehabilitation use restorative (drill-and-practice) and compensatory (management) strategies. Yet most cognitive interventions for persons with MS are predominantly visual or speech-focused, which eliminates the possibility of stimulating multiple senses.

Music consists of complex, multidomain stimuli that engage a large bilateral network of temporal, frontal, parietal, cerebellar, limbic, and paralimbic brain areas associated with multiple parallel cognitive, verbal, motor, and emotional processes. Playing a musical instrument involves intricate coordination and communication between multiple sensory systems (visual, auditory, tactile) and motor functions. As individuals read and translate musical notes into physical actions, they simultaneously receive feedback from their auditory system. The ability to engage these systems and coordinate multiple domains may induce new cortical pathways fostering neuroplasticity. This rewiring in the brain created by repeated musical practice can create alternate pathways and structures to help those with MS compensate for deficits caused by demyelinating disease. Music interventions for other neurodegenerative conditions have been studied, but very few have been implemented for those with MS. A recent systematic review evaluated the impact of active (singing, dancing, instrument playing) and passive (listening) music interventions on psychosocial and neurological outcomes in individuals with MS. Of the 15 studies reviewed, none examined a music learning intervention and the impact on cognitive impairment-a critical gap to be addressed.

Our multi-disciplinary team has conducted a proof-of-concept study to evaluate an innovative ukulele training intervention, Music-4-MS, to address the gap in cognitive rehabilitation for persons with MS. Based on the feedback from participants in that study, our team of experts in human and music learning, music therapy, neuroscience, nursing, and cognitive rehabilitation optimized Music-4-MS. The primary goal of the present study is to evaluate the feasibility of the optimized Music-4-MS as a manualized eHealth intervention. Guided by the therapeutic music capacities model, Music-4-MS will support cognitive, psychosocial, and functional well-being. In a prospective, randomized (1:1) trial with 64 individuals with MS recruited nationwide, the Music-4-MS group will be compared with an active control group. This will be a step toward a larger clinical trial to test the intervention's efficacy in improving MS health outcomes. The specific aims are as follows:

Aim 1: To determine the feasibility and acceptability of delivering the optimized Music-4-MS eHealth intervention to individuals with MS over 12 weeks.

Aim 2: To evaluate the preliminary effect of the optimized Music-4-MS on cognitive (objective performance, subjective function), psychosocial (anxiety, depression, social function), and functional (physical function, fatigue, hand dexterity) well-being over time in the Music-4-MS versus the active control group.

Aim 3: To explore participants' perceptions of the motivation, engagement, connection, and usefulness of Music-4-MS in their daily lives.

02

Conditions studied

  • Multiple Sclerosis
  • Pathologic Processes
  • Demyelinating Autoimmune Diseases, CNS
  • Autoimmune Diseases of the Nervous System
  • Nervous System Diseases
  • Demyelinating Diseases
  • Autoimmune Diseases
  • Immune System Diseases

Keywords

  • Cognitive rehabilitation
03

In context

Multiple Sclerosis

3,264 studies on the registry are indexed under Multiple Sclerosis; 659 are open to participants now.

This study's planned enrollment of 64 is above the median of 50 across 2,201 interventional studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

University of Texas at Austin is the lead sponsor of 328 studies on the registry; 79 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 5 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed with multiple sclerosis (relapsing remitting, secondary progressive, primary progressive)
  • Diagnosed more than 6 months prior to starting study
  • Self-reported cognitive impairment as assessed by having at leased 5 problems "sometimes" or more often on the Perceived Deficits Questionnaire
  • Read, write, and understand English
  • Access to internet

Exclusion criteria

Exclusion Criteria:

  • Diagnosed with another neurological condition that causes cognitive impairment
  • MS exacerbation within the last 30 days
  • Professional musician (primary source of income)
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
64 participants (estimated)

Study arms

  • Experimental
    Musical Training Intervention

    Participants randomized to this arm receive a 12-week intervention to teach them how to play the ukulele. The ukulele is a very manageable instrument to learn and requires less hand dexterity than other stringed instruments. Each week participants will follow the musical training intervention (MTI) protocol that provides instruction on how to tune, hold, and strum the ukulele and play basic chords. To practice the chords, they will also learn popular songs (e.g., Chain of Fools, Three Little Birds, Happy Birthday, Just the Way You Are, and Coconut). Participants will be instructed to follow each session outlined weekly and asked to practice the instrument for at least 30 minutes, 5 days a week. They will be given a paper and digital version of the MTI protocol. A member of our research team will call the participants weekly to answer any questions about the MTI protocol.

    Behavioral: Music Training Intervention

  • Active comparator
    Music Listening

    Participants randomized to this arm will be asked to listen to their preferred music for at least 30 minutes, 5 days a week. A member of our research team will call them every week to answer any questions they have about the ML protocol. They will be asked to record their experience in a daily log.

    Behavioral: Music Listening

Interventions

  • BehavioralMusic Training Intervention

    The Music Training Intervention (MTI) entails 12-weeks of online instruction to learn to play the ukulele. Participants will be taught the basic information on how to hold the ukulele, musical chords, strum and play popular songs. They will be instructed to play at least 30-minutes a day, five days a week.

  • BehavioralMusic Listening

    Participants randomized to this arm will be asked to listen to their preferred music for at least 30 minutes, 5 days a week. A member of our research team will call them every week to answer any questions they have about the ML protocol. They will be asked to record their experience in a daily log

06

What researchers measure

Primary outcomes

  1. Feasibility: Engagement

    Feasibility will be assessed by quantifying weekly participation in Music-4-MS using the activity metrics from the online platform Teachable.

    Time frame: Immediately post-intervention

  2. Feasibility: Retention

    Feasibility will be evaluated by quantifying how many participants drop out throughout the course of the study.

    Time frame: Immediately post-intervention

  3. Feasibility: Recruitment

    Feasibility will be assessed by quantifying how many people accept the invitation to participate in the study.

    Time frame: Immediately post-intervention

  4. Musical Training Intervention Acceptability

    Acceptability will be evaluated with semi-structured interview questions to understand the participant's perception of MTI delivery and content and the perceived impact.

    Time frame: Immediately post-intervention

  5. Music Listening Intervention Acceptability

    Acceptability will be assessed by having participants rate a series of eight statements from 1 (Strongly Disagree) to 7 (Strongly Agree), and answer three open-ended questions based on their experience with the music listening program.

    Time frame: Immediately post-intervention

Secondary outcomes

  1. Mean Change from Baseline in Functional Well-Being Scores at 12 weeks and 16 weeks

    The Patient-Reported Outcomes Measurement Information System (PROMIS)-29 Profile v2.0 will be used. The survey measures physical function, anxiety, depression, fatigue, sleep disturbance, ability to participate in social roles and activities, and pain interference. Each domain is scored from 4 to 20.

    Time frame: Immediately post-intervention and 1-month post-intervention

  2. Mean Change from Baseline in Cognitive Function at 12 weeks and 16 weeks

    The Patient-Reported Outcomes Measurement Information System (PROMIS) Cognition Function Short-Form will be used. The minimum score is 8, and the maximum score is 40. Higher scores indicate more cognitive impairment.

    Time frame: Immediately post-intervention and 1-month post-intervention

  3. Mean Change from Baseline in Upper Extremity Function Scores at 12 weeks and 16 weeks

    The Patient-Reported Outcomes Measurement Information System (PROMIS) Upper Extremity Function (Fine Motor, ADL) - Short Form will be used. The minimum score is 8, and the maximum score is 40. Higher scores indicate more more upper extremity function.

    Time frame: Immediately post-intervention and 1-month post-intervention

  4. Mean Change from Baseline in Objective Hand Dexterity Scores at 12 weeks and 16 weeks

    The 9-Hole Peg Test (9HPT) will be used. The 9HPT is a timed task completed with both hands independently, with a lower time indicating more hand dexterity.

    Time frame: Immediately post-intervention and 1-month post-intervention

  5. Mean Change from Baseline in Subjective Hand Dexterity Scores at 12 weeks and 16 weeks

    The ABILHAND Questionnaire will be used. There are 26 activities listed and the participants responds with impossible, difficult, or easy to complete. An increased number of impossible and difficult responses indicates lower hand dexterity.

    Time frame: Immediately post-intervention and 1-month post-intervention

  6. Mean Change from Baseline in Loneliness Scores at 12 weeks and 16 weeks.

    The NIH Toolbox - Emotional Battery Loneliness will be used. It is a 5-item survey with responses graded on a 5-point scale from 'never' to 'always' assessing feelings of loneliness and social isolation.

    Time frame: Immediately post-intervention and 1-month post-intervention

  7. Mean Change from Baseline in Attention Scores at 12 weeks and 16 weeks

    The Trail Making A\&B will be used to measure attention. Trails A and B are two separate timed tests. Faster time means greater attention.

    Time frame: Immediately post-intervention and 1-month post-intervention

  8. Mean Change from Baseline in Memory Scores at 12 weeks and 16 weeks

    Immediate and delayed recognition tests will be used. Participant are shown 10 words to memorize. In the immediate recognition test, they are immediately asked to identify the 10 words they memorized out of a list of 20. Later in the testing series, participants will again be asked to recall the 10 words. The number of correct responses will be scored. Higher scores means better memory.

    Time frame: Immediately post-intervention and 1-month post-intervention

  9. Mean Change from Baseline in Executive Functioning Scores at 12 weeks and 16 weeks

    The Digit-Symbol Substitution will be used to measure processing speed and accuracy to evaluate executive functioning. In this test, participants match arbitrary symbols to digits. Scores are calculated by the number of trials correctly completed in 60 seconds.

    Time frame: Immediately post-intervention and 1-month post-intervention

  10. Mean Change from Baseline in Executive Functioning Scores at 12 weeks and 16 weeks

    The Stroop Color and Word Test evaluates impulse control and inhibition to evaluate executive functioning. When the name of a color (e.g., "blue," "green," or "red") is displayed in an incongruent color, name (for example, the word "blue" printed in red), naming the color of the word takes longer and is more prone to errors than when the word and color are congruent or neutral. The scoring uses median duration of incongruent trials.

    Time frame: Immediately post-intervention and 1-month post-intervention

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07759115
Responsible party
Carolyn Phillips (Assistant Professor, University of Texas at Austin) — Principal investigator
First posted
Aug 12, 2026
Start date
Aug 10, 2026
Primary completion
Mar 2028 (estimated)
Completion
Aug 2028 (estimated)
Last update
Aug 17, 2026

Study contacts

Carolyn Phillips, PhD, RN
Contact
carolyn.phillips@nursing.utexas.edu
512-475-7039
Carolyn Phillips, PhD
principal investigator · University of Texas at Austin

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion